To ask Her Majesty's Government, further to the Written Answer by Lord Bourne of Aberystwyth on 15 May (HL7448), when section 7 of the Neighbourhood Planning Act 2017 will be brought into force.
- Contact information
- Parliamentary career
- Experience
- Focus areas
- Voting record
- Spoken contributions
- Written questions
- Register of Interests
- APPG officer roles
- Staff
- Official portrait
Written questions
Review the written questions submitted by Baroness Cumberlege.
To perform a more comprehensive search of written questions, visit the Parliamentary written questions and answers website.
To ask Her Majesty's Government what provisions of the Neighbourhood Planning Act 2017 have not yet been brought into force.
To ask Her Majesty’s Government what assessment they have made of how England compares with other European countries in (1) one, (2) five, and (3) 10-year survival rates for patients diagnosed with metastatic kidney cancer.
To ask Her Majesty’s Government whether cancer treatments submitted to, but not assessed by, the National Institute for Health and Care Excellence (NICE) before 1 April will be approved under the new NICE framework for cancer treatments.
To ask Her Majesty’s Government what assessment they have made of the average time from diagnosis to treatment for patients with metastatic kidney cancer in England.
To ask Her Majesty’s Government whether, in the light of the report by Maternity Action and the Refugee Council When maternity doesn’t matter: dispersing pregnant women seeking asylum, they plan to publish revised guidance on procedures for dispersing and...
To ask Her Majesty’s Government when the NHS Five Year Forward View taskforce on cancer services will report back on their initial assessment of opportunities to improve cancer care before March 2015; and when in 2015 they will present the new five year s...
To ask Her Majesty’s Government what focus the NHS Five Year Forward View taskforce on cancer services, chaired by Cancer Research UK, will give to molecular diagnostics.
To ask Her Majesty’s Government which pharmaceutical companies have informed NHS England about the withdrawal of their funding for molecular testing; and what plans NHS England has in place to ensure continuity of funding and access for affected patients.
To ask Her Majesty’s Government what commissioning policies and interventions are in place to ensure uninterrupted access to molecular diagnostics from 1 April 2015 whilst a more robust system is being developed.
To ask Her Majesty’s Government what measures NHS England is putting in place to ensure the development of a national policy for molecular diagnostic testing before existing legacy arrangements expire in 2016; who will lead those plans; when they will beg...
To ask Her Majesty’s Government what are the terms of reference for the forthcoming consultation on the National Tariff.